Learn more about the International Society of Pharmacoepidemiology’s Annual Meeting. The Rutgers Center for Pharmacoepidemiology and Treatment Sciences (PETS) facilitates and performs innovative, multidisciplinary science related to the use and … Read More
The Rutgers Center for Pharmacoepidemiology and Treatment Sciences (PETS) facilitates and performs innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. The mission of the … Read More
The Rutgers Center for Pharmacoepidemiology and Treatment Sciences (PETS) facilitates and performs innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. The mission of the … Read More
The Rutgers Center for Pharmacoepidemiology and Treatment Sciences (PETS) facilitates and performs innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. The mission of the … Read More
Date June 24, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu PETS core faculty member, Dr. Soko Setoguchi, joined Dr. Robert Centor on the Annals on Call podcast from … Read More
Date May 26, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu The Rutgers Center for Pharmacoepidemiology and Treatment Science extends a warm welcome to Monica D’Arcy, MS, PhD, new Core … Read More
About Monica D’Arcy is a cancer and pharmacoepidemiologist. She received her undergraduate degrees in mathematics and computer science engineering from the University of Pennsylvania, her MS in epidemiology from Temple … Read More
About Daniel Horton is a pediatric rheumatologist and pharmacoepidemiologist who performs clinical, translational, and health services research. He started at Rutgers in 2016 as an Assistant Professor and Chancellor’s Scholar … Read More
By Patti Verbanas Date March 22, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu Medication for opioid use disorder was lowest among adolescents and adults ages 50 or older, Rutgers … Read More
About Brian Strom is currently serving as an Inaugural Chancellor at Rutgers Biomedical and Health Sciences. He also holds the position of Executive Vice President for Health Affairs at Rutgers … Read More